Annual Total Liabilities
N/A
December 1, 2024
Summary
- EW annual total liabilities is not available.
Performance
EW Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Total Liabilities
N/A
December 1, 2024
Summary
- EW quarterly total liabilities is not available.
Performance
EW Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
EW Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
EW Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Edwards Lifesciences Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.36 B(+29.5%) |
| Jun 2024 | - | $2.59 B(+1.8%) |
| Mar 2024 | - | $2.55 B(-3.6%) |
| Dec 2023 | $2.64 B(+6.4%) | $2.64 B(+0.0%) |
| Sep 2023 | - | $2.64 B(+3.4%) |
| Jun 2023 | - | $2.56 B(-1.2%) |
| Mar 2023 | - | $2.59 B(+4.2%) |
| Dec 2022 | $2.49 B(-6.8%) | $2.49 B(+2.7%) |
| Sep 2022 | - | $2.42 B(-2.5%) |
| Jun 2022 | - | $2.48 B(-3.6%) |
| Mar 2022 | - | $2.58 B(-3.4%) |
| Dec 2021 | $2.67 B(+0.1%) | $2.67 B(+1.8%) |
| Sep 2021 | - | $2.62 B(+3.6%) |
| Jun 2021 | - | $2.53 B(-1.0%) |
| Mar 2021 | - | $2.56 B(-4.0%) |
| Dec 2020 | $2.66 B(+13.8%) | $2.66 B(+2.8%) |
| Sep 2020 | - | $2.59 B(+0.2%) |
| Jun 2020 | - | $2.58 B(+18.9%) |
| Mar 2020 | - | $2.17 B(-7.0%) |
| Dec 2019 | $2.34 B(+7.2%) | $2.34 B(+8.8%) |
| Sep 2019 | - | $2.15 B(+3.8%) |
| Jun 2019 | - | $2.07 B(+2.5%) |
| Mar 2019 | - | $2.02 B(-7.4%) |
| Dec 2018 | $2.18 B(-19.4%) | $2.18 B(-15.9%) |
| Sep 2018 | - | $2.60 B(+3.0%) |
| Jun 2018 | - | $2.52 B(-2.2%) |
| Mar 2018 | - | $2.58 B(-4.8%) |
| Dec 2017 | $2.71 B(+43.3%) | $2.71 B(+16.5%) |
| Sep 2017 | - | $2.33 B(+5.8%) |
| Jun 2017 | - | $2.20 B(+7.9%) |
| Mar 2017 | - | $2.04 B(+7.8%) |
| Dec 2016 | $1.89 B(+21.7%) | $1.89 B(+14.8%) |
| Sep 2016 | - | $1.65 B(+4.2%) |
| Jun 2016 | - | $1.58 B(+1.7%) |
| Mar 2016 | - | $1.55 B(+0.1%) |
| Dec 2015 | $1.55 B(+16.6%) | $1.55 B(+6.7%) |
| Sep 2015 | - | $1.46 B(+10.3%) |
| Jun 2015 | - | $1.32 B(+3.5%) |
| Mar 2015 | - | $1.27 B(-4.3%) |
| Dec 2014 | $1.33 B(+14.3%) | $1.33 B(+1.9%) |
| Sep 2014 | - | $1.31 B(-7.4%) |
| Jun 2014 | - | $1.41 B(+7.7%) |
| Mar 2014 | - | $1.31 B(+12.5%) |
| Dec 2013 | $1.17 B(+57.0%) | $1.17 B(+6.6%) |
| Sep 2013 | - | $1.09 B(+43.9%) |
| Jun 2013 | - | $759.90 M(+7.8%) |
| Mar 2013 | - | $704.60 M(-5.1%) |
| Dec 2012 | $742.20 M | $742.20 M(+12.5%) |
| Sep 2012 | - | $659.50 M(+3.0%) |
| Jun 2012 | - | $640.50 M(+4.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $613.90 M(-4.5%) |
| Dec 2011 | $642.60 M(+40.0%) | $642.60 M(+2.3%) |
| Sep 2011 | - | $628.30 M(+1.8%) |
| Jun 2011 | - | $617.20 M(+7.7%) |
| Mar 2011 | - | $573.30 M(+24.9%) |
| Dec 2010 | $459.00 M(+0.3%) | $459.00 M(-6.7%) |
| Sep 2010 | - | $491.90 M(-6.1%) |
| Jun 2010 | - | $524.10 M(+15.7%) |
| Mar 2010 | - | $452.90 M(-1.0%) |
| Dec 2009 | $457.60 M(-12.2%) | $457.60 M(-10.6%) |
| Sep 2009 | - | $511.70 M(+10.8%) |
| Jun 2009 | - | $462.00 M(+11.2%) |
| Mar 2009 | - | $415.60 M(-20.3%) |
| Dec 2008 | $521.40 M(+2.2%) | $521.40 M(+2.9%) |
| Sep 2008 | - | $506.70 M(+12.4%) |
| Jun 2008 | - | $451.00 M(-15.3%) |
| Mar 2008 | - | $532.70 M(+4.4%) |
| Dec 2007 | $510.10 M(+2.6%) | $510.10 M(+7.2%) |
| Sep 2007 | - | $475.90 M(+7.1%) |
| Jun 2007 | - | $444.30 M(-4.3%) |
| Mar 2007 | - | $464.20 M(-6.7%) |
| Dec 2006 | $497.40 M(-7.7%) | $497.40 M(-2.9%) |
| Sep 2006 | - | $512.40 M(-4.5%) |
| Jun 2006 | - | $536.80 M(+4.0%) |
| Mar 2006 | - | $516.00 M(-4.3%) |
| Dec 2005 | $539.10 M(+11.2%) | $539.10 M(+11.0%) |
| Sep 2005 | - | $485.80 M(-0.7%) |
| Jun 2005 | - | $489.10 M(+3.0%) |
| Mar 2005 | - | $475.00 M(-2.0%) |
| Dec 2004 | $484.60 M(+3.9%) | $484.60 M(+2.5%) |
| Sep 2004 | - | $472.60 M(-6.1%) |
| Jun 2004 | - | $503.40 M(-5.7%) |
| Mar 2004 | - | $533.60 M(+14.4%) |
| Dec 2003 | $466.30 M(+0.3%) | $466.30 M(-5.2%) |
| Sep 2003 | - | $492.10 M(-5.5%) |
| Jun 2003 | - | $520.70 M(+5.6%) |
| Mar 2003 | - | $492.90 M(+6.0%) |
| Dec 2002 | $465.00 M(-11.3%) | $465.00 M(+1.2%) |
| Sep 2002 | - | $459.60 M(-8.8%) |
| Jun 2002 | - | $503.70 M(+5.1%) |
| Mar 2002 | - | $479.10 M(-8.6%) |
| Dec 2001 | $524.20 M(-21.4%) | $524.20 M(-4.2%) |
| Sep 2001 | - | $547.00 M(-7.5%) |
| Jun 2001 | - | $591.50 M(-7.4%) |
| Mar 2001 | - | $638.90 M(-4.2%) |
| Dec 2000 | $667.00 M(+213.1%) | $667.00 M(-2.1%) |
| Sep 2000 | - | $681.40 M(-4.3%) |
| Jun 2000 | - | $712.00 M(+2.0%) |
| Mar 2000 | - | $698.00 M |
| Dec 1999 | $213.00 M | - |
FAQ
- What is the all time high annual total liabilities for Edwards Lifesciences?
- What is the all time high quarterly total liabilities for Edwards Lifesciences?
What is the all time high annual total liabilities for Edwards Lifesciences?
Edwards Lifesciences all-time high annual total liabilities is $2.71 B
What is the all time high quarterly total liabilities for Edwards Lifesciences?
Edwards Lifesciences all-time high quarterly total liabilities is $3.36 B